Long-term remission of human immunodeficiency virus-associated visceral leishmaniasis after initiation of potent combination antiretroviral treatment: report of two cases.
We describe two cases of human immunodeficiency virus-infected patients with visceral leishmaniasis in whom no clinical and parasitological disease relapses were observed after liposomal amphotericin B therapy combined with potent antiretroviral treatment.
Mastroianni
C M
CM
Department of Infectious and Tropical Diseases, La Sapienza University, Rome, Italy.
d'Ettorre
G
G
Forcina
G
G
Corpolongo
A
A
Dell'Isola
S
S
Lichtner
M
M
D'Agostino
C
C
Trinchieri
V
V
Santopadre
P
P
Vullo
V
V
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000469:parasitology; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000469:parasitology; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D000981:Antiprotozoal Agents; D018894:Reverse Transcriptase Inhibitors; C068538:liposomal amphotericin B; D000666:Amphotericin B